Enhanced Staphylococcus aureus protection by uncoupling of the α-toxin-ADAM10 interaction during murine neonatal vaccination
Staphylococcus aureus remains a leading global cause of bacterial infection-associated mortality and has eluded prior vaccine development efforts. S. aureus α-toxin (Hla) is an essential virulence factor in disease, impairing the T cell response to infection. The anti-Hla antibody response is a corr...
Saved in:
| Published in: | Nature communications Vol. 15; no. 1; pp. 8702 - 14 |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
London
Nature Publishing Group UK
08.10.2024
Nature Publishing Group Nature Portfolio |
| Subjects: | |
| ISSN: | 2041-1723, 2041-1723 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Staphylococcus aureus
remains a leading global cause of bacterial infection-associated mortality and has eluded prior vaccine development efforts.
S. aureus
α-toxin (Hla) is an essential virulence factor in disease, impairing the T cell response to infection. The anti-Hla antibody response is a correlate of human protective immunity. Here we observe that this response is limited early in human life and design a vaccine strategy to elicit immune protection against Hla in a neonatal mice. By targeted disruption of the interaction of Hla with its receptor ADAM10, we identify a vaccine antigen (Hla
H
35L/
R
66C/
E
70C
, Hla
HRE
) that elicits an ~100-fold increase in the neutralizing anti-Hla response. Immunization with Hla
HRE
enhances the T follicular helper (T
FH
) cell response to
S. aureus
infection, correlating with the magnitude of the neutralizing anti-toxin response and disease protection. Furthermore, maternal Hla
HRE
immunization confers protection to offspring. Together, these findings illuminate a path for
S. aureus
vaccine development at the maternal-infant interface.
Staphylococcus aureus
infection results in robust induction of immunity but the development of efficacious vaccines remains challenging. Here the authors present a vaccine that amplifies T cell immunity early in life by targeting the
S. aureus
α-toxin-ADAM10 interaction in a murine model. |
|---|---|
| Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ISSN: | 2041-1723 2041-1723 |
| DOI: | 10.1038/s41467-024-52714-7 |